Genomics-enabled drug repositioning and repurposing: insights from an IOM Roundtable activity.
Publication
, Journal Article
Power, A; Berger, AC; Ginsburg, GS
Published in: JAMA
May 2014
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
May 2014
Volume
311
Issue
20
Start / End Page
2063 / 2064
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Translational Research, Biomedical
- Research Support as Topic
- National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division
- Genomics
- General & Internal Medicine
- Drug Repositioning
- Drug Industry
- 42 Health sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Power, A., Berger, A. C., & Ginsburg, G. S. (2014). Genomics-enabled drug repositioning and repurposing: insights from an IOM Roundtable activity. JAMA, 311(20), 2063–2064. https://doi.org/10.1001/jama.2014.3002
Power, Aidan, Adam C. Berger, and Geoffrey S. Ginsburg. “Genomics-enabled drug repositioning and repurposing: insights from an IOM Roundtable activity.” JAMA 311, no. 20 (May 2014): 2063–64. https://doi.org/10.1001/jama.2014.3002.
Power A, Berger AC, Ginsburg GS. Genomics-enabled drug repositioning and repurposing: insights from an IOM Roundtable activity. JAMA. 2014 May;311(20):2063–4.
Power, Aidan, et al. “Genomics-enabled drug repositioning and repurposing: insights from an IOM Roundtable activity.” JAMA, vol. 311, no. 20, May 2014, pp. 2063–64. Pubmed, doi:10.1001/jama.2014.3002.
Power A, Berger AC, Ginsburg GS. Genomics-enabled drug repositioning and repurposing: insights from an IOM Roundtable activity. JAMA. 2014 May;311(20):2063–2064.
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
May 2014
Volume
311
Issue
20
Start / End Page
2063 / 2064
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Translational Research, Biomedical
- Research Support as Topic
- National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division
- Genomics
- General & Internal Medicine
- Drug Repositioning
- Drug Industry
- 42 Health sciences